Kimia Biosciences Limited (BOM:530313)

India · Delayed Price · Currency is INR

31.61

+0.61 (1.97%)

At close: Jul 31, 2026

-48.64% (1Y)

Market Cap	1.50B -48.6%
Revenue (ttm)	1.15B -3.4%
Net Income	74.34M -22.7%
EPS	1.64 -19.2%
Shares Out	47.31M
PE Ratio	19.27
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,215
Open	31.49
Previous Close	31.00
Day's Range	30.20 - 31.93
52-Week Range	23.20 - 61.99
Beta	1.16
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 13, 2026

About Kimia Biosciences

Kimia Biosciences Limited manufactures and sells active pharmaceutical ingredients (APIs) in India. The company offers and develops APIs in the categories, including gastrointestinal agent, anti-coagulant, anti-hypertensive, lipid lowering agents, vitamin, anti-histamine, anti-convulsant, central stimulant, anti-diabetic, and anti-bacterial, as well as anti-psychotic, anti-fungal, urologicals, anti-inflammatory, prokinetic agent, cholelithiasis agent, anti-asthmatic, anti-depressant, anti-acne, decongestant, and anti-virals. It exports its prod... [Read more]

Industry Medicinal Chemicals and Botanical Products

Founded 1993

Employees 250

Stock Exchange Bombay Stock Exchange

Ticker Symbol 530313

Full Company Profile

Financial Performance

In fiscal year 2026, Kimia Biosciences's revenue was 1.15 billion, a decrease of -3.39% compared to the previous year's 1.19 billion. Earnings were 74.34 million, a decrease of -22.67%.

Financial Statements